tci Medicare Compliance & Reimbursement - 2005 Issue 29
PHARMACEUTICALS: Providers Frustrated By CMS CAP Get Relief
Subscribe or sign in to view the full article.
Article Overview
This article explains CMS updates to the Competitive Acquisition Program for Part B drugs and summarizes why some physicians viewed the program as difficult to use. It is relevant to Medicare billing, physician practices, oncology, and other providers who administer Part B drugs incident to professional services. The article covers the rule type, comment timeline, administration scheduling flexibility, and categories of drugs included or excluded from the program at a high level.
Why This Topic Matters
Providers and coding/billing staff need to understand changes affecting Medicare drug acquisition and administration workflows, especially when CMS modifies participation requirements and the scope of drugs covered under the program.
Article Sections
-
CMS responds to provider concerns
Overview of the agency's rulemaking approach and the additional opportunity for comment on the program changes.
-
Seven-day administration window
Discussion of the timing flexibility CMS allows for planned drug administration and the provider reaction to that change.
-
Drugs covered and excluded under the CAP
Summary of the program’s covered drug universe and broad categories of items that are excluded from participation.
What You Will Learn
- How CMS changed the Competitive Acquisition Program rulemaking process
- What general scheduling flexibility is described for planned drug administration
- Which broad categories of drugs are included or excluded from the program
- Why some physicians viewed the program as difficult to operationalize
Who Should Read This
- Physicians
- Medical coders
- Billing staff
- Practice managers
- Oncology practices
- Medicare reimbursement professionals
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com